MINGCHEN HEALTH(002919)

Search documents
名臣健康(002919) - 关于控股股东部分股份质押的公告
2025-07-25 09:15
证券代码:002919 证券简称:名臣健康 公告编号:2025-026 名臣健康用品股份有限公司 关于控股股东部分股份质押的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 名臣健康用品股份有限公司(以下简称"公司")近日收到公司控股股东陈 勤发先生的告知函,获悉陈勤发先生将其所持公司部分股份办理了质押手续,具 体事项如下: | 是否为控股 | 是否 | 占其所 | 占公司 | 是否 | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东 | 股东或第一 | 本次质押股 | 为补 | 质押起始 | 质押到 | 质权 | 质押 | 持股份 | 总股本 | 为限 | | | | | 名称 | 大股东及其 | 份数量(股) | 充质 | 日 | 期日 | 人 | 用途 | 比例 | 比例 | 售股 | | | | | 一致行动人 | 押 | | | | | | | | | | | | | | 兴业 ...
名臣健康(002919) - 关于回购股份方案实施完毕暨回购实施结果的公告
2025-07-22 09:47
证券代码:002919 证券简称:名臣健康 公告编号:2025-025 名臣健康用品股份有限公司 关于回购股份方案实施完毕暨回购实施结 果的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 名臣健康用品股份有限公司(以下简称"公司")于2025年5月20日召开公 司第四届董事会第五次会议,审议通过了《关于回购公司股份方案的议案》。公 司拟使用自有资金以集中竞价交易的方式回购公司股份,用于实施股权激励计划 或员工持股计划,回购股份的种类为公司发行的人民币普通股(A 股)。本次回 购股份资金总额不低于人民币3,000万元(含)且不超过人民币5,000万元(含), 回购股份价格不超过人民币23.00元/股(含),回购期限自董事会审议通过回购 股份议案之日起不超过12个月。具体内容详见公司在《证券日报》、《证券时报》、 《中国证券报》、《上海证券报》和巨潮资讯网(www.cninfo.com.cn)披露的 《关于回购公司股份方案的公告》(公告编号:2025-014)及《回购股份报告书》 (公告编号:2025-017)。 由于公司实施了2024年度权益分派,根据公司 ...
传媒行业周报系列2025年第26周:多国关税谈判期限将至,25H1电影票房为近六年最高-20250706
HUAXI Securities· 2025-07-06 12:58
Investment Rating - The industry rating is "Recommended" indicating a positive outlook for the sector [4]. Core Insights & Investment Recommendations - The report highlights the upcoming deadline for tariff negotiations, which may increase external trade uncertainties. However, there remains a cautious optimism regarding the substantive implementation of existing trade agreements [2][23]. - The film box office for the first half of 2025 reached 29.231 billion yuan, marking a 22.91% year-on-year increase and the best performance in six years. The top five films were all domestic productions, showcasing the resilience of domestic entertainment consumption and the strengthening of the content ecosystem [2][24]. - The report suggests focusing on investment opportunities in the following areas: 1) Hong Kong internet leaders, 2) the gaming industry, and 3) the film and cultural tourism sector, driven by consumption policies that promote recovery [3][24]. Summary by Sections Market Overview - In the week of June 30 to July 4, 2025, the Shanghai Composite Index rose by 1.4%, while the SW Media Index increased by 2.7%, ranking 6th among 31 industries [10][16]. Sub-industry Data Film Industry - The top three films for the week were "Jurassic World: Rebirth" with a box office of 18.175 million yuan, "Detective Conan: The Lone Eye's Residue" with 8.402 million yuan, and "F1: Speeding" with 7.569 million yuan [25][26]. Gaming Industry - The top three iOS games were "Honor of Kings," "Peacekeeper Elite," and "Delta Force," while the top three Android games were "Heartbeat Town," "Honkai: Star Rail," and "Staff Sword Legend" [25][26]. TV Series - The top three TV series based on broadcast index were "In the Name of the Law," "Splendid Blossoms," and "Book Roll Dream" [28][29]. Variety Shows & Animation - The top variety show was "Ha Ha Ha Ha Season 5," followed by "Run, Brother Season 9" and "New Rap 2025" [30]. The leading animation was "Cang Yuan Tu: The Beauty Award" [31].
名臣健康(002919) - 关于回购公司股份的进展公告
2025-07-02 08:02
证券代码:002919 证券简称:名臣健康 公告编号:2025-024 名臣健康用品股份有限公司 关于回购公司股份的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 二、其他说明 (一)公司首次回购股份的时间、回购股份数量及集中竞价交易的委托时段 符合《深圳证券交易所上市公司自律监管指引第9号——回购股份》第十七条、 十八条的相关规定。 1、公司未在下列期间回购公司股份: 名臣健康用品股份有限公司(以下简称"公司")于2025年5月20日召开公 司第四届董事会第五次会议,审议通过了《关于回购公司股份方案的议案》。公 司拟使用自有资金以集中竞价交易的方式回购公司股份,用于实施股权激励计划 或员工持股计划,回购股份的种类为公司发行的人民币普通股(A 股)。本次回 购股份资金总额不低于人民币3,000万元(含)且不超过人民币5,000万元(含), 回购股份价格不超过人民币23.00元/股(含),回购期限自董事会审议通过回购 股份议案之日起不超过12个月。具体内容详见公司在《证券日报》、《证券时报》、 《中国证券报》、《上海证券报》和巨潮资讯网(www.cni ...
名臣健康: 关于为全资子公司提供担保的进展公告
Zheng Quan Zhi Xing· 2025-06-19 09:52
证券代码:002919 证券简称:名臣健康 公告编号:2025-023 名臣健康用品股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 一、担保情况概述 名臣健康用品股份有限公司(以下简称"公司")于 2025 年 4 月 28 日召开第 四届董事会第四次会议、2025 年 5 月 20 日召开 2024 年年度股东大会审议通过 《关于为全资子公司申请银行授信提供担保的议案》,同意公司为全资子公司广 东名臣日化有限公司(以下简称"名臣日化")提供不超过 16,000 万元的连带责 任保证担保,本次担保额度有效期为自公司 2024 年年度股东大会审议通过之日 起 2 年内。在上述额度范围内,公司董事会申请股东大会授权公司总经理或总经 理指定的授权代理人,在批准额度范围内负责具体组织实施担保事项并签署相关 文件。具体内容详见公司披露于巨潮资讯网(www.cninfo.com.cn)的相关公告。 二、担保进展情况 近日,公司与中国建设银行股份有限公司汕头市分行(以下简称"银行") 签订《最高额保证合同》(合同编号:HTC440650000ZGB2025N0 ...
名臣健康(002919) - 关于为全资子公司提供担保的进展公告
2025-06-19 09:30
证券代码:002919 证券简称:名臣健康 公告编号:2025-023 名臣健康用品股份有限公司 关于为全资子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 一、担保情况概述 6、经营范围:一般项目:日用化学产品制造;日用化学产品销售;化妆品 批发;食品用洗涤剂销售;消毒剂销售(不含危险化学品);家居用品制造;家 居用品销售;塑料包装箱及容器制造;塑料制品制造;个人卫生用品销售;日用 百货销售;技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广; 食品进出口;货物进出口;技术进出口。(除依法须经批准的项目外,凭营业执 照依法自主开展经营活动)许可项目:化妆品生产;食品用洗涤剂生产;消毒剂 生产(不含危险化学品);卫生用品和一次性使用医疗用品生产;包装装潢印刷 品印刷;检验检测服务。(依法须经批准的项目,经相关部门批准后方可开展经 营活动,具体经营项目以相关部门批准文件或许可证件为准) 7、与本公司关系:名臣日化系公司全资子公司。 名臣健康用品股份有限公司(以下简称"公司")于 2025 年 4 月 28 日召开第 四届董事会第四 ...
传媒行业周报系列2025年第23周:中美原则上达成协议框架,OpenAI发布o3pro模型-20250615
HUAXI Securities· 2025-06-15 09:00
Investment Rating - The industry rating is "Recommended" [4] Core Insights & Investment Recommendations - The recent US-China trade negotiations in London have reached a principled framework, indicating substantial progress in managing differences and stabilizing economic relations, which may support global supply chain recovery [2][21] - OpenAI has launched the new o3-pro model, reducing its price by 80% and input/output costs by 87%, reflecting a shift towards efficiency optimization in large model technology and accelerating AI technology penetration into small and medium enterprises [2][21] - The report maintains a cautious optimism regarding trade negotiations and highlights AI as a key investment direction amid global macroeconomic volatility, emphasizing the importance of technological innovation and self-sufficiency for long-term development [3][22] Sub-industry Data Film Industry - The top three films by box office this week are "How to Train Your Dragon: The Hidden World" with 58.175 million yuan (25.6% market share), "Mission: Impossible 8" with 54.90 million yuan (24.2%), and "Time Son" with 28.366 million yuan (12.5%) [24][25] Gaming Industry - The top three iOS games by revenue are "Honor of Kings," "Peacekeeper Elite," and "Endless Winter," while the top three Android games by popularity are "Heart Town," "Sword Legend," and "My Leisure Time" [27][28] TV Series Industry - The top three TV series by broadcast index are "The Cang Hai Chuan," "Lin Jiang Xian," and "The Lychee of Chang'an," with indices of 85.3, 84.2, and 82.2 respectively [30][31] Variety Shows & Animation - The top variety show is "Ha Ha Ha Ha Season 5" with a broadcast index of 80.6, followed by "Run, Brother Season 9" and "Unlimited Exceeding Class Season 3" [32] - The top three animated shows by viewership index are "Cang Yuan Tu," "Xian Ni," and "Perfect World," with indices of 340.2, 225, and 222.5 respectively [34]
名臣健康(002919) - 关于首次回购公司股份的公告
2025-06-10 09:02
证券代码:002919 证券简称:名臣健康 公告编号:2025-022 名臣健康用品股份有限公司 关于首次回购公司股份的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 名臣健康用品股份有限公司(以下简称"公司")于2025年5月20日召开公 司第四届董事会第五次会议,审议通过了《关于回购公司股份方案的议案》。公 司拟使用自有资金以集中竞价交易的方式回购公司股份,用于实施股权激励计划 或员工持股计划,回购股份的种类为公司发行的人民币普通股(A 股)。本次回 购股份资金总额不低于人民币3,000万元(含)且不超过人民币5,000万元(含), 回购股份价格不超过人民币23.00元/股(含),回购期限自董事会审议通过回购 股份议案之日起不超过12个月。具体内容详见公司在《证券日报》、《证券时报》、 《中国证券报》、《上海证券报》和巨潮资讯网(www.cninfo.com.cn)披露的 《关于回购公司股份方案的公告》(公告编号:2025-014)及《回购股份报告书》 (公告编号:2025-017)。 由于公司实施了2024年度权益分派,根据公司本次回购股份方案及《回购股 份报告书》等相关规定,公 ...
名臣健康:首次回购公司股份40万股
news flash· 2025-06-10 08:47
Group 1 - The company Mingchen Health (002919) announced a share buyback plan, which will be implemented through centralized bidding starting from June 10, 2025 [1] - The total number of shares to be repurchased is 400,000, representing 0.15% of the company's current total share capital [1] - The maximum transaction price for the buyback is set at 16.5 yuan per share, while the minimum price is 16.3 yuan per share, with a total transaction amount of 6.5634 million yuan (excluding transaction fees) [1] Group 2 - The buyback plan complies with the company's share repurchase scheme and relevant laws and regulations [1]
6月9日晚间重要公告一览
Xi Niu Cai Jing· 2025-06-09 10:15
Group 1 - Kaichun Co., Ltd. adjusted the share repurchase price limit from 26.625 yuan/share to 40 yuan/share, effective from June 10, 2025 [1] - Yipin Pharmaceutical's subsidiary received a drug registration certificate for Dexmedetomidine Hydrochloride Injection, a Class 3 chemical drug used for sedation during anesthesia [1] - Bohui Innovation obtained a medical device registration certificate for HPV Genotyping Test Kit, used for qualitative detection of HPV DNA [1][2] Group 2 - Lingyi Zhi Zao's application for issuing convertible bonds and cash payment to acquire 66.46% of Jiangsu Kedasiteng Automotive Technology Co., Ltd. has been accepted by the Shenzhen Stock Exchange [3] - Kemin Food reported a 23.06% year-on-year increase in pig sales in May, with a total of 48,300 pigs sold [4][5] - Meian Sen decided to terminate the issuance of shares to specific objects due to market conditions and strategic considerations [6][7] Group 3 - Zhengbang Technology reported a 146.6% year-on-year increase in pig sales revenue in May, totaling 731 million yuan [9] - Yuanda Holdings plans to reduce the registered capital of its subsidiary from 73 million to 24.3 million USD to optimize asset structure [10] - East China Pharmaceutical's subsidiary received FDA approval for clinical trials of HDM1010 tablets for type 2 diabetes [12] Group 4 - Liangxin Co., Ltd. received a government subsidy of 14.1 million yuan, accounting for 4.52% of its audited net profit for 2024 [13] - Erkang Pharmaceutical's Vitamin B6 Injection passed the consistency evaluation for generic drugs [14] - New Industry received a patent certificate for an antibody related to anti-PIC detection, enhancing detection efficiency [16][15] Group 5 - Dongxing Medical signed a 6 million yuan technology development contract with Shanghai Jiao Tong University for collagen preparation processes [16] - Suchang Chai A's subsidiary will absorb and merge another subsidiary, adjusting internal equity structure [17] - Yibin Technology received a project designation notice from a domestic new energy vehicle company, with an estimated total sales of 256 million yuan over five years [18] Group 6 - Mingchen Health received a cash dividend of 20 million yuan from its subsidiary [19] - Hendi Pharmaceutical obtained a drug registration certificate for Ibuprofen Suspension, a common medication for children [19] - Huaren Pharmaceutical's subsidiary received a drug registration certificate for Dexmedetomidine Hydrochloride Injection, classified as a Category B drug under national medical insurance [20] Group 7 - Enwei Pharmaceutical obtained a renewed drug production license for six key products [21] - Xiaoming Co., Ltd. reported a 45.59% year-on-year increase in chicken product sales in May, totaling 23.25 million birds [23][24] - Shan Natural Gas successfully issued a 350 million yuan short-term financing bond with a 1.78% interest rate [25] Group 8 - Xidamen announced plans for board members to reduce their holdings by up to 581,000 shares [26] - Shentong Technology's shareholder plans to reduce holdings by up to 3% of the company's shares [27] - Saintno Bio plans to distribute a cash dividend of 0.14 yuan per share and a capital increase of 0.4 shares per share [28] Group 9 - *ST King Kong's subsidiary received a debt transfer notice from its controlling shareholder, totaling 364 million yuan [29] - Foxit Software's executives plan to reduce their holdings by a total of 55,800 shares [30] - Youyou Green Energy plans to apply for a bank credit line of up to 1.5 billion yuan [31] Group 10 - Guoxing Optoelectronics plans to distribute a cash dividend of 0.5 yuan per 10 shares [32] - Guangxun Technology plans to distribute a cash dividend of 2.6 yuan per 10 shares [33] - Hanrui Cobalt plans to distribute a cash dividend of 1.5 yuan per 10 shares [35] Group 11 - Tigermed plans to distribute a cash dividend of 3 yuan per 10 shares [37] - Shenliang Holdings plans to distribute a cash dividend of 1.5 yuan per 10 shares [38] - Yishitong plans to distribute a cash dividend of 1 yuan per 10 shares [39]